(4)——0.50.01Other1.10.30.80.01Adjusted (Non-U.S. GAAP)$172.0$33.4$147.8$2.04Twelve Months ended December 31, 2025OperatingprofitIncometaxexpenseNetincomeDilutedEPSReported (U.S. GAAP)$584.9$121.6$493.7$6.79Unallocated items:Restructuring and other charges (1)23.30.922.40.31SmartDose® 3.5mL sale (2)8.41.96.50.09Cost-method investment activity (3)4.5—4.50.06Amortization of acquisition-related intangible assets (4)0.2—2.00.03Other1.10.30.80.01Adjusted (Non-U.S. GAAP)$622.4$124.7$529.9$7.29Three Months ended De ...